Combination Chemotherapy with 5-Fluorouracil and Heptaplatin as First-line Treatment in Patients with Advanced Gastric Cancer

Heptaplatin is a recently developed platinum derivative. This agent has been reported to have a response rate of 17% as a single agent, and tolerable toxicity in the treatment of advanced gastric cancer. The aim of this study was to evaluate the efficacy and toxicity of a combination of 5-fluorourac...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Young Joo, Bang, Sung-Jo, Shin, Jung Woo, Kim, Do Ha, Park, Jae Hoo, Kim, Gyu Yeol, Ko, Byung Kyun, Choi, Dae Hwa, Cho, Hong Rae
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2004
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816837/
https://www.ncbi.nlm.nih.gov/pubmed/15201502
http://dx.doi.org/10.3346/jkms.2004.19.3.369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816837/
https://www.ncbi.nlm.nih.gov/pubmed/15201502
http://dx.doi.org/10.3346/jkms.2004.19.3.369

Ejemplares similares